OBiS is a New York City-based company that was founded in 2002 by Rick Beasley, former Director of Oncology Market Research at Bristol-Myers Squibb. Initially, OBiS developed competitive intelligence tools for oncology sales forces and medical science liaison specialists. Over time, we have expanded our offerings to include clinical trial recruitment profiling tools, key opinion leader identification (KOL), and business forecasting services. In July 2020, OBiS opened a subsidiary office in France to develop its analytical capabilities and better serve European markets. Today, OBiS is known for having one of the most comprehensive business-focused knowledge bases of new and existing medicines, which allows us to offer clients fast, accurate, and insightful analytical products and services with broad coverage across all human disease areas.